株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

VTT Technical Research Centre of Finlandの製品パイプライン分析

VTT Technical Research Centre of Finland - Product Pipeline Review - 2014

発行 Global Markets Direct 商品コード 318945
出版日 ページ情報 英文 17 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: Global Markets Direct社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
VTT Technical Research Centre of Finlandの製品パイプライン分析 VTT Technical Research Centre of Finland - Product Pipeline Review - 2014
出版日: 2014年11月14日 ページ情報: 英文 17 Pages
概要

VTT Technical Research Centre of Finlandはフィンランドに本社を置く研究組織で、ユビキタス知能、スマート産業、バイオエコノミーへの転換、低炭素エネルギー、ヘルス&ウェルネス、インフラおよび都市計画などをはじめとする高度な技術ソリューションやサービスを提供しています。

当レポートでは、VTT Technical Research Centre of Finlandにおける治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

目次

VTT Technical Research Centre of Finlandの基本情報

  • VTT Technical Research Centre of Finlandの概要
  • 主要情報
  • 企業情報

VTT Technical Research Centre of Finland:R&Dの概要

  • 主な治療範囲

VTT Technical Research Centre of Finland:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

VTT Technical Research Centre of Finland:パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 創薬中の製品/併用療法モダリティ

VTT Technical Research Centre of Finland:薬剤プロファイル

  • Anti-Mitotic siRNA for Cancer
  • MicroRNA for Cancer
  • Small Molecule Anti-Mitotics for Cancer

VTT Technical Research Centre of Finland:パイプライン分析

VTT Technical Research Centre of Finland:分子タイプ別のパイプライン製品

VTT Technical Research Centre of Finland:開発休止中のプロジェクト

VTT Technical Research Centre of Finland:本社と子会社の所在地

  • 本社
  • 支社および子会社

付録

図表一覧

目次
Product Code: GMDHC06495CDB

Summary

Global Markets Direct's, 'VTT Technical Research Centre of Finland - Product Pipeline Review - 2014', provides an overview of the VTT Technical Research Centre of Finland's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of VTT Technical Research Centre of Finland's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of VTT Technical Research Centre of Finland including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of VTT Technical Research Centre of Finland's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the VTT Technical Research Centre of Finland's pipeline products

Reasons to buy

  • Evaluate VTT Technical Research Centre of Finland's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of VTT Technical Research Centre of Finland in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the VTT Technical Research Centre of Finland's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of VTT Technical Research Centre of Finland and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of VTT Technical Research Centre of Finland
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of VTT Technical Research Centre of Finland and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • VTT Technical Research Centre of Finland Snapshot
    • VTT Technical Research Centre of Finland Overview
    • Key Information
    • Key Facts
  • VTT Technical Research Centre of Finland - Research and Development Overview
    • Key Therapeutic Areas
  • VTT Technical Research Centre of Finland - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • VTT Technical Research Centre of Finland - Pipeline Products Glance
    • VTT Technical Research Centre of Finland - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • VTT Technical Research Centre of Finland - Drug Profiles
    • Anti-Mitotic siRNA for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MicroRNA for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule Anti-Mitotics for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • VTT Technical Research Centre of Finland - Pipeline Analysis
  • VTT Technical Research Centre of Finland - Pipeline Products by Molecule Type
  • VTT Technical Research Centre of Finland - Dormant Projects
  • VTT Technical Research Centre of Finland - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • VTT Technical Research Centre of Finland, Key Information
  • VTT Technical Research Centre of Finland, Key Facts
  • VTT Technical Research Centre of Finland - Pipeline by Indication, 2014
  • VTT Technical Research Centre of Finland - Pipeline by Stage of Development, 2014
  • VTT Technical Research Centre of Finland - Monotherapy Products in Pipeline, 2014
  • VTT Technical Research Centre of Finland - Discovery, 2014
  • VTT Technical Research Centre of Finland - Pipeline by Molecule Type, 2014
  • VTT Technical Research Centre of Finland - Dormant Developmental Projects,2014
  • VTT Technical Research Centre of Finland, Subsidiaries

List of Figures

  • VTT Technical Research Centre of Finland - Pipeline by Top 10 Molecule Type, 2014
Back to Top